Toyota Tomoko 豊田知子

… Alternative Names

豊田知子トヨタトモコ

Less

Researcher Number	30596432
Other IDs
Affiliation (Current)	2022: 産業医科大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2019 – 2021: 産業医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 52020:Neurology-related Except Principal Investigator Basic Section 52020:Neurology-related
Keywords	Principal Investigator 進行性ミオクローヌスてんかん / 歯状核赤核淡蒼球ルイ体萎縮症 / mTOR / オートファジー / ポリグルタミン病 Except Principal Investigator ポリグルタミン病 / HIKESHI / 凝集体形成抑制 / 分子シャペロン / 毒性軽減

The development of disease- modifying therapies for progressive myoclonus epilepsyPrincipal Investigator
- Principal Investigator
  
  豊田知子
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52020:Neurology-related
- Research Institution
  University of Occupational and Environmental Health, Japan
Reducing toxicity of disease-causative molecules with the aim of developing therapies for neurodegenarative diseases
- Principal Investigator
  
  足立弘明
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52020:Neurology-related
- Research Institution
  University of Occupational and Environmental Health, Japan

All 2019

All Presentation

[Presentation] Dynactin-1 implicates autophagosome-lysosome fusion defects in the neurodegenerative diseases.2019
- Author(s)
  足立弘明, 黄哲, 岡田和将, 大成圭子, 橋本智代, 豊田知子, 岩中行己男
- Organizer
  第60回日本神経学会学術大会
- Data Source
  KAKENHI-PROJECT-19K07970

1. 足立弘明 (40432257)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Toyota Tomoko 豊田知子

豊田知子トヨタトモコ

Research Projects

Research Products

Co-Researchers

The development of disease- modifying therapies for progressive myoclonus epilepsyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Reducing toxicity of disease-causative molecules with the aim of developing therapies for neurodegenarative diseases

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Presentation] Dynactin-1 implicates autophagosome-lysosome fusion defects in the neurodegenerative diseases.2019

Author(s)

Organizer

Data Source

Toyota Tomoko 豊田 知子

豊田 知子 トヨタ トモコ

Research Projects

Research Products

Co-Researchers

The development of disease- modifying therapies for progressive myoclonus epilepsyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Reducing toxicity of disease-causative molecules with the aim of developing therapies for neurodegenarative diseases

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Presentation] Dynactin-1 implicates autophagosome-lysosome fusion defects in the neurodegenerative diseases.2019

Author(s)

Organizer

Data Source

Toyota Tomoko 豊田知子

豊田知子トヨタトモコ